NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Study of MIRCERA in Participants With Chronic Kidney Disease Stage 3-4 and Not on Dialysis

CompletedN/A

Sponsor: Hoffmann-La Roche

Conditions: Anemia

Interventions: MIRCERA

Countries: Sweden

An observational, longitudinal, multi-center, non-interventional study in participants with chronic kidney disease (CKD) stage 3-4, assessed by Modification of Diet in Renal Disease (MDRD) to collect data regarding safety and efficacy in participants with pre-dialysis situation who are treated with MIRCERA in normal clinical environment.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Adult participants above 18 years of age
* Pre-dialysis participants with CKD stage 3-4 treated with MIRCERA and continue in the pre-dialysis state for the whole study period
* Estimated glomerular filteration rate (e-GFR) between 15-60 milliliter per minute (mL/min) (calculated)

Exclusion Criteria:

* Participants involved in interventional trials
* Participants with life expectancy less than 1 year
* Active malignancy
* Planned living kidney transplant within 6 months.

Locations (20)

Angeholm, Sweden
Bollnäs, Sweden
Eskilstuna, Sweden
Gävle, Sweden
Gothenburg, Sweden
Gothenburg, Sweden
Huddinge, Sweden
Jönköping, Sweden
Karlshamn, Sweden
Karlstad, Sweden
Kristianstad, Sweden
Linköping, Sweden
Mölndal, Sweden
Norrköping, Sweden
Skövde, Sweden
Stockholm, Sweden
Stockholm, Sweden
Umeå, Sweden
Värnamo, Sweden
Västervik, Sweden